Found 14 matching trials
Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis NA The aim of this study is to assess efficacy of the different adjuvant chemo...
Show More Location
Liver Cancer Insitute, Zhongshan Hospital
Learn More & Join Trial
TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion NA This is a prospective, randomized study designed to compare the efficacy of...
Show More Location
The First Hospital of Hebei Medical University
Learn More & Join Trial
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma PHASE3 This is a phase III, multicenter, open-label, randomized controlled trial d...
Show More Location
The First Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma PHASE4 Previous studies have confirmed that limb pain caused by oxaliplatin chemot...
Show More Location
The Second Affiliated Hospital, Chongqing Medical University
Learn More & Join Trial
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome PHASE2 Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens PHASE2 Liver metastasis is the main reason that affects the survival rates of pati...
Show More Location
the first affiliated hospital, Sun-Yat sen university
Learn More & Join Trial
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma N/A Systemic therapy is the primary option for managing advanced hepatocellular...
Show More Learn More & Join Trial
The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study N/A This is a multicenter, retrospective study planned to enroll patients with ...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma PHASE2 The purpose of this study is to determine that systemic chemotherapy is sup...
Show More Location
Multiple Locations
Learn More & Join Trial